查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1537024

乳房切片市場:全球產業分析，規模，佔有率，成長，趨勢，預測，2024-2033年

Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 353 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球乳房切片市場的詳細研究報告。該報告詳細分析了主要市場動態，包括市場推動因素、趨勢、機會和課題，並提供了對市場結構的全面見解。

主要洞察

  • 乳房切片市場規模（2024 年）：23 億美元
  • 預測市值（2033 年）：38 億美元
  • 全球市場成長率（2024 年至 2033 年複合年增長率）：5.7%

乳房切片市場 - 報告範圍：

乳房切片市場包括各種透過採集小組織樣本進行測試來診斷乳癌的產品。該市場包括不同類型的乳房活檢，例如針吸活檢、開放式手術活檢和真空輔助活檢，這對於癌症的早期檢測和診斷至關重要。該市場服務於醫院、診斷中心和門診手術中心等不同領域，並透過直銷和醫療用品商店等多種管道進行分銷。乳癌篩檢意識的提高、乳癌盛行率的增加以及活檢技術的進步推動了這一增長。

推動市場成長的因素：

推動全球乳房切片市場的因素有多個。全球乳癌發生率上升推動了乳房切片檢查的需求。活檢設備和技術的技術進步正在提高這些手術的準確性和舒適度，刺激市場擴張。此外，對早期乳癌篩檢和診斷的認識和承諾的提高正在推動對乳房活檢的需求。醫療保健支出的增加和對預防性健康措施的關注也有助於市場擴張。

市場阻礙因素：

儘管成長前景廣闊，但乳房活檢市場面臨著與先進活檢設備和程序的高成本以及與其使用相關的潛在問題（例如不適和感染風險）相關的課題。市場也受到有關醫療器材安全的嚴格法規以及持續創新以滿足不斷變化的臨床需求的需求的影響。解決這些問題並保持競爭力需要有效的病患教育、有競爭力的定價以及持續性研發投資。

市場機會：

市場開發致力於開發高品質、微創活檢設備，以滿足對準確、舒適的診斷解決方案不斷增長的需求。新興經濟體醫療保健基礎設施的擴張為市場成長提供了新的管道，並使公司能夠接觸到更多的人。城市化進程的加速和健康意識的增強正在推動對乳房活檢的需求。戰略合作夥伴關係、新技術投資以及創新活檢設備的推出對於利用新商機和保持市場領先至關重要。

本報告涵蓋的主要問題

  • 推動全球乳房切片市場成長的關鍵因素是什麼？
  • 哪些類型和應用的乳房切片檢查程序在各種環境中廣泛採用？
  • 技術進步如何影響乳房切片市場的競爭格局？
  • 誰是乳房切片市場的主要參與者？
  • 全球乳房切片市場的新趨勢和未來前景如何？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制
  • 蘊藏和排除

第3章 主要市場趨勢

  • 影響市場的主要趨勢
  • 產品革新/開發趨勢

第4章 附加價值的洞察

  • 產品的採用/使用情形分析
  • 各製造廠商的主要的推銷策略
  • 法規情勢
  • 大環境分析
  • 波特分析
  • 新產品的銷售
  • 技術評估

第5章 市場背景

  • 宏觀經濟要素
  • 預測要素- 相關性及影響
  • 市場動態

第6章 COVID-19危機分析

  • COVID-19及影響分析
    • 各產品收益
    • 各適應症收益
    • 各終端用戶收益
    • 各國收益
  • 2024年的市場情勢

第7章 全球市場的需求(數量)分析

  • 市場(數量)分析，2019～2023年
  • 市場(數量)預測，2024～2033年
    • 前一年同期比較成長趨勢分析

第8章 全球市場- 價格分析

  • 各產品的各地區價格分析
  • 價格的明細
    • 廠商級的價格設定
    • 分銷商級的價格設定
  • 世界平均價格分析基準
  • 價格設定的前提

第9章 全球市場的需求(金額)分析

  • 市場(金額)分析，2019～2023年
  • 市場(金額)預測，2024～2033年
    • 前一年同期比較成長趨勢分析
    • 絕對的商機

第10章 各產品:全球市場分析

  • 簡介/主要調查結果
  • 市場規模(金額及數量)分析，2019～2023年
  • 市場規模(金額及數量)析與預測，2024～2033年
    • 切片穿刺針
      • 粗針切片
      • 細微吸引針
    • MRI指南切片檢查系統
    • 超音波指南下乳房切片系統
      • 2維(2D)乳房X光攝影超音波掃描系統
      • 3維(3D)B方式乳房X光攝影超音波掃描系統
    • 吸引輔助設備(VAD)
    • 導管導引線(定位線)
    • 乳房切片標記
  • 各產品市場魅力分析

第11章 各適應症:全球市場分析

  • 簡介/主要調查結果
  • 市場規模(金額)分析，2019～2023年
  • 市場規模(金額)析與預測，2024～2033年
    • 複雜囊胞
    • 固體塊兒
    • 可疑的固態腫疙瘩(線維腺瘤)
    • 可疑的微小鈣化
  • 各適應症的市場魅力分析

第12章 各終端用戶:全球市場分析

  • 簡介/主要調查結果
  • 市場規模(金額)分析，2019～2023年
  • 市場規模(金額)析與預測，2024～2033年
    • 醫院
    • 專門診所
    • 門診病人手術中心
    • 癌症調查機關
  • 各終端用戶市場魅力分析

第13章 各地區:全球市場分析

  • 簡介
  • 市場規模(金額及數量)分析，2019～2023年
  • 市場規模(金額及數量)分析與預測，2024～2033年
    • 北美
    • 南美
    • 歐洲
    • 南亞
    • 東亞
    • 大洋洲
    • 中東·非洲(中東·非洲)
  • 各地區市場的魅力分析

第14章 北美市場分析

第15章 南美市場分析

第16章 歐洲市場分析

第17章 南亞市場分析

第18章 東亞市場分析

第19章 大洋洲市場分析

第20章 中東·非洲市場分析

第21章 市場結構分析

  • 各級企業市場分析
  • 主要企業的市場佔有率分析(%)
  • 市場影響分析

第22章 競爭分析

  • 競爭儀表板
  • 主要業者的品牌和推銷策略
  • 主要開發分析
  • 競爭詳細內容
    • Argon Medical Devices
    • Becton Dickinson and Company
    • CR Bard, Inc.
    • Cook Medical Inc.
    • Devicor Medical Products, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare
    • Hologic, Inc.
    • Leica Biosystems
    • Medax Srl Unipersonale
    • Planmed Oy
    • Scion Medical Technologies, LLC
    • Siemens Healthineer

第23章 所使用的前提條件與縮寫

第24章 調查手法

簡介目錄
Product Code: PMRREP33464

Persistence Market Research has recently published a detailed report on the global Breast Biopsy Market. This report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing comprehensive insights into the market structure.

Key Insights:

  • Breast Biopsy Market Size (2024E): USD 2.3 Bn
  • Projected Market Value (2033F): USD 3.8 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.7%

Breast Biopsy Market - Report Scope:

The Breast Biopsy Market encompasses a variety of products designed to diagnose breast cancer by removing a small tissue sample for examination. This market includes different types of breast biopsy procedures, such as needle biopsy, open surgical biopsy, and vacuum-assisted biopsy, which are essential for early cancer detection and diagnosis. The market serves diverse segments, including hospitals, diagnostic centers, and ambulatory surgical centers, distributed through various channels like direct sales and medical supply distributors. Growth is driven by increasing awareness of breast cancer screening, rising prevalence of breast cancer, and technological advancements in biopsy techniques.

Market Growth Drivers:

Several key factors drive the global Breast Biopsy Market. The rising incidence of breast cancer globally boosts the demand for breast biopsy procedures. Technological advancements in biopsy devices and techniques enhance the accuracy and comfort of these procedures, fueling market expansion. Additionally, the growing awareness and initiatives for early breast cancer screening and diagnosis drive the demand for breast biopsy. Increased healthcare expenditure and a focus on preventive health measures also contribute to market growth.

Market Restraints:

Despite promising growth prospects, the Breast Biopsy Market faces challenges related to the high cost of advanced biopsy devices and procedures and potential issues associated with their use, such as discomfort and risk of infection. The market is also impacted by the presence of stringent regulations on medical device safety and the need for continuous innovation to meet evolving clinical needs. Effective patient education, competitive pricing, and ongoing investment in research and development are necessary to address these issues and maintain a competitive edge.

Market Opportunities:

The market presents significant opportunities driven by the rising trend of early cancer detection and increasing awareness about the benefits of breast cancer screening.The development of high-quality and minimally invasive biopsy devices caters to the growing demand for accurate and comfortable diagnostic solutions. The expansion of healthcare infrastructure in emerging economies provides new channels for market growth, allowing companies to reach a broader audience. Increasing urbanization and the rising number of health-conscious individuals drive the demand for breast biopsy procedures. Strategic partnerships, investments in new technologies, and the introduction of innovative biopsy devices are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Breast Biopsy Market globally?
  • Which types and applications of breast biopsy procedures are leading the adoption in various settings?
  • How are technological advancements influencing the competitive landscape of the Breast Biopsy Market?
  • Who are the key players in the Breast Biopsy Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Breast Biopsy Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Breast Biopsy Market, including Hologic, Inc., Becton, Dickinson and Company, and Leica Biosystems, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced biopsy devices and techniques, such as vacuum-assisted and stereotactic biopsy systems. Collaborations with healthcare providers, research institutions, and medical device distributors facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving Breast Biopsy Market landscape.

Key Companies Profiled:

  • Argon Medical
  • Becton Dickinson and Company
  • C.R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineers
  • Hikma Pharmaceuticals
  • Incytes

Breast Biopsy Market Industry Segmentation

By Product:

  • Biopsy Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
  • Vacuum-Assisted Devices (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Markers

Indication:

  • Complex Cysts
  • Solid Mass
  • Suspicious Solid Mass (Fibroadenoma)
  • Suspicious Micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusion

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Value Added Insights

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Key Promotional Strategies, by Manufacturers
  • 4.3. Regulatory Scenario
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. New Product Launches
  • 4.7. Technology Assessment

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Rising demand for Breast Biopsy Devices
    • 5.2.2. Cost of Procedures
    • 5.2.3. Adoption Rate
    • 5.2.4. Increase in Research and Development
    • 5.2.5. Availability of Product
    • 5.2.6. Strategic Mergers and Collaborations Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. Revenue by Product
    • 6.1.2. Revenue By Indication
    • 6.1.3. Revenue By End User
    • 6.1.4. Revenue By Country
  • 6.2. 2024 Market Scenario

7. Global Market Demand (in Volume Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis by Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) & Volume (Units) Analysis by Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Biopsy Needle
      • 10.3.1.1. Core Needles
      • 10.3.1.2. Fine Aspiration Needles
    • 10.3.2. MRI-Guide Biopsy Systems
    • 10.3.3. Ultrasound Guided Breast Biopsy Systems
      • 10.3.3.1. Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
      • 10.3.3.2. Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 10.3.4. Vacuum-Assisted Device (VAD)
    • 10.3.5. Guide Wire (Localization Wire)
    • 10.3.6. Breast Biopsy Marker
  • 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Indication, 2024-2033
    • 11.3.1. Complex Cyst
    • 11.3.2. Solid Mass
    • 11.3.3. Suspicious Solid Mass (Fibroadenoma)
    • 11.3.4. Suspicious Micro Calcifications
  • 11.4. Market Attractiveness Analysis by Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Specialty Clinics
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Cancer Research Institutes
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East & Africa(MEA)
  • 13.4. Market Attractiveness Analysis by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. U.S. Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By End User
    • 14.8.2. Canada Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By End-User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast recast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Brazil Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By End User
    • 15.8.2. Mexico Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By End User
    • 15.8.3. Argentina Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. Russia
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By End User
    • 16.8.2. Italy Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By End User
    • 16.8.3. France Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By End User
    • 16.8.4. U.K. Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By End User
    • 16.8.5. Spain Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Indication
        • 16.8.5.2.3. By End User
    • 16.8.6. BENELUX Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Indication
        • 16.8.6.2.3. By End User
    • 16.8.7. Nordic Countries Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Indication
        • 16.8.7.2.3. By End User
    • 16.8.8. Russia Market
      • 16.8.8.1. Introduction
      • 16.8.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.8.2.1. By Product
        • 16.8.8.2.2. By Indication
        • 16.8.8.2.3. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Indication
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By End User
    • 17.8.2. Thailand Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By End User
    • 17.8.3. Indonesia Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By End User
    • 17.8.4. Malaysia Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Indication
        • 17.8.4.2.3. By End User

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. China Market
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By End User
    • 18.8.2. Japan Market
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By End User
    • 18.8.3. South Korea Market
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By End User

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By End User
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. Australia Market
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By End User
    • 19.8.2. New Zealand Market
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By End User

20. Middle East & Africa Market Analysis 2019-2023and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of MEA
    • 20.3.2. By Product
    • 20.3.3. By Indication
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Indication
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Country Level Analysis & Forecast
    • 20.8.1. GCC Countries Market
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Indication
        • 20.8.1.2.3. By End User
    • 20.8.2. Turkiye Market
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Indication
        • 20.8.2.2.3. By End User
    • 20.8.3. South Africa Market
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Indication
        • 20.8.3.2.3. By End User
    • 20.8.4. North Africa Market
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Indication
        • 20.8.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players (%)
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Branding and Promotional Strategies, by Key Players
  • 22.3. Key Development Analysis
  • 22.4. Competition Deep Dive
    • 22.4.1. Argon Medical Devices
      • 22.4.1.1. Overview
      • 22.4.1.2. Product Portfolio
      • 22.4.1.3. Key Financial
      • 22.4.1.4. Sales Footprint
      • 22.4.1.5. SWOT Analysis
      • 22.4.1.6. Strategy Overview
        • 22.4.1.6.1. Marketing Strategies
        • 22.4.1.6.2. Product Strategies
        • 22.4.1.6.3. Channel Strategies
    • 22.4.2. Becton Dickinson and Company
      • 22.4.2.1. Overview
      • 22.4.2.2. Product Portfolio
      • 22.4.2.3. Key Financial
      • 22.4.2.4. Sales Footprint
      • 22.4.2.5. SWOT Analysis
      • 22.4.2.6. Strategy Overview
        • 22.4.2.6.1. Marketing Strategies
        • 22.4.2.6.2. Product Strategies
        • 22.4.2.6.3. Channel Strategies
    • 22.4.3. C. R. Bard, Inc.
      • 22.4.3.1. Overview
      • 22.4.3.2. Product Portfolio
      • 22.4.3.3. Key Financial
      • 22.4.3.4. Sales Footprint
      • 22.4.3.5. SWOT Analysis
      • 22.4.3.6. Strategy Overview
        • 22.4.3.6.1. Marketing Strategies
        • 22.4.3.6.2. Product Strategies
        • 22.4.3.6.3. Channel Strategies
    • 22.4.4. Cook Medical Inc.
      • 22.4.4.1. Overview
      • 22.4.4.2. Product Portfolio
      • 22.4.4.3. Key Financial
      • 22.4.4.4. Sales Footprint
      • 22.4.4.5. SWOT Analysis
      • 22.4.4.6. Strategy Overview
        • 22.4.4.6.1. Marketing Strategies
        • 22.4.4.6.2. Product Strategies
        • 22.4.4.6.3. Channel Strategies
    • 22.4.5. Devicor Medical Products, Inc.
      • 22.4.5.1. Overview
      • 22.4.5.2. Product Portfolio
      • 22.4.5.3. Key Financial
      • 22.4.5.4. Sales Footprint
      • 22.4.5.5. SWOT Analysis
      • 22.4.5.6. Strategy Overview
        • 22.4.5.6.1. Marketing Strategies
        • 22.4.5.6.2. Product Strategies
        • 22.4.5.6.3. Channel Strategies
    • 22.4.6. F. Hoffmann-La Roche Ltd.
      • 22.4.6.1. Overview
      • 22.4.6.2. Product Portfolio
      • 22.4.6.3. Key Financial
      • 22.4.6.4. Sales Footprint
      • 22.4.6.5. SWOT Analysis
      • 22.4.6.6. Strategy Overview
        • 22.4.6.6.1. Marketing Strategies
        • 22.4.6.6.2. Product Strategies
        • 22.4.6.6.3. Channel Strategies
    • 22.4.7. GE Healthcare
      • 22.4.7.1. Overview
      • 22.4.7.2. Product Portfolio
      • 22.4.7.3. Key Financial
      • 22.4.7.4. Sales Footprint
      • 22.4.7.5. SWOT Analysis
      • 22.4.7.6. Strategy Overview
        • 22.4.7.6.1. Marketing Strategies
        • 22.4.7.6.2. Product Strategies
        • 22.4.7.6.3. Channel Strategies
    • 22.4.8. Hologic, Inc.
      • 22.4.8.1. Overview
      • 22.4.8.2. Product Portfolio
      • 22.4.8.3. Key Financial
      • 22.4.8.4. Sales Footprint
      • 22.4.8.5. SWOT Analysis
      • 22.4.8.6. Strategy Overview
        • 22.4.8.6.1. Marketing Strategies
        • 22.4.8.6.2. Product Strategies
        • 22.4.8.6.3. Channel Strategies
    • 22.4.9. Leica Biosystems
      • 22.4.9.1. Overview
      • 22.4.9.2. Product Portfolio
      • 22.4.9.3. Key Financial
      • 22.4.9.4. Sales Footprint
      • 22.4.9.5. SWOT Analysis
      • 22.4.9.6. Strategy Overview
        • 22.4.9.6.1. Marketing Strategies
        • 22.4.9.6.2. Product Strategies
        • 22.4.9.6.3. Channel Strategies
    • 22.4.10. Medax Srl Unipersonale
      • 22.4.10.1. Overview
      • 22.4.10.2. Product Portfolio
      • 22.4.10.3. Key Financial
      • 22.4.10.4. Sales Footprint
      • 22.4.10.5. SWOT Analysis
      • 22.4.10.6. Strategy Overview
        • 22.4.10.6.1. Marketing Strategies
        • 22.4.10.6.2. Product Strategies
        • 22.4.10.6.3. Channel Strategies
    • 22.4.11. Planmed Oy
      • 22.4.11.1. Overview
      • 22.4.11.2. Product Portfolio
      • 22.4.11.3. Key Financial
      • 22.4.11.4. Sales Footprint
      • 22.4.11.5. SWOT Analysis
      • 22.4.11.6. Strategy Overview
        • 22.4.11.6.1. Marketing Strategies
        • 22.4.11.6.2. Product Strategies
        • 22.4.11.6.3. Channel Strategies
    • 22.4.12. Scion Medical Technologies, LLC
      • 22.4.12.1. Overview
      • 22.4.12.2. Product Portfolio
      • 22.4.12.3. Key Financial
      • 22.4.12.4. Sales Footprint
      • 22.4.12.5. SWOT Analysis
      • 22.4.12.6. Strategy Overview
        • 22.4.12.6.1. Marketing Strategies
        • 22.4.12.6.2. Product Strategies
        • 22.4.12.6.3. Channel Strategies
    • 22.4.13. Siemens Healthineer
      • 22.4.13.1. Overview
      • 22.4.13.2. Product Portfolio
      • 22.4.13.3. Key Financial
      • 22.4.13.4. Sales Footprint
      • 22.4.13.5. SWOT Analysis
      • 22.4.13.6. Strategy Overview
        • 22.4.13.6.1. Marketing Strategies
        • 22.4.13.6.2. Product Strategies
        • 22.4.13.6.3. Channel Strategies

23. Assumptions and Acronyms Used

24. Research Methodology